Publications by authors named "G Verhoef"

Claim this Profile
D
Divergent prognostic utility of metabolic risk scores in large B-cell lymphoma subtypes: a real-world analysis.
Vibeke K J Vergote, Gregor Verhoef, Ann Janssens, F J S Woei-A-Jin, Wies Deckers

Eur J Nucl Med Mol Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Metabolic Prognostic Index Is Superior to Other Metabolic Tumor Volume-Based Prognostication Methods in a Real-Life Cohort of Diffuse Large B-Cell Lymphoma.
Vibeke K J Vergote, Gregor Verhoef, Ann Janssens, F J Sherida H Woei-A-Jin, Wies Deckers

J Nucl Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma.
Georg Lenz, Eliza Hawkes, Gregor Verhoef, Corinne Haioun, Soon Thye Lim

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The iR regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: A multicentre, non-randomised, open-label phase 2 study.
Radhakrishnan Ramchandren, Peter Johnson, Nilanjan Ghosh, Jia Ruan, Kirit M Ardeshna, Gregor Verhoef

EClinicalMedicine· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 Years.
Vibeke K J Vergote, Christophe M Deroose, Steffen Fieuws, Wim Laleman, Ben Sprangers, Gregor Verhoef

Transpl Int· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis